Goldman Sachs initiates coverage on Zealand Pharma A/S (NASDAQ: ZEAL) with a Buy rating.Analyst Keyur Parekh believes the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE